We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.65%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
23.15%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
339
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$5.45M |
| 2 |
Altimmune
ALT
|
+$4.45M |
| 3 |
FRC
First Republic Bank
FRC
|
+$4.06M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.99M |
| 5 |
Hilton Worldwide
HLT
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Rayonier Advanced Materials
RYAM
$610M
| $157K | 0.02% |
+25,037
| New | +$175K |
|
|
THRX
1302
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $156K | 0.02% |
+17,543
| New | +$172K |
|
|
JOAN
1303
DELISTED
JOANN, Inc. Common Stock
JOAN
| $152K | 0.02% |
+95,862
| New | +$308K |
|
|
CBAY
1304
DELISTED
Cymabay Therapeutics
CBAY
| $152K | 0.02% |
17,468
-48,861
| -74% | -$391K |
|
1305
Regis Corp
RGS
$70.2M
| $151K | 0.01% |
6,785
-47
| -0.7% | -$1.3K |
|
1306
Editas Medicine
EDIT
$442M
| $149K | 0.01% |
20,549
+1,803
| +10% | +$16K |
|
|
LUNA
1307
DELISTED
Luna Innovations Incorporated
LUNA
| $149K | 0.01% |
20,688
-38,075
| -65% | -$336K |
|
1308
Invesco S&P SmallCap Energy ETF
PSCE
$97.7M
| $148K | 0.01% |
+3,191
| New | +$160K |
|
1309
Dole
DOLE
$1.32B
| $146K | 0.01% |
+12,446
| New | +$139K |
|
|
BGRY
1310
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $145K | 0.01% |
105,333
+47,449
| +82% | +$56.5K |
|
1311
Invesco Mortgage Capital
IVR
$805M
| $144K | 0.01% |
+12,947
| New | +$167K |
|
1312
Phathom Pharmaceuticals
PHAT
$692M
| $144K | 0.01% |
20,232
+1,715
| +9% | +$15.1K |
|
|
RENT
1313
Rent the Runway
RENT
$124M
| $142K | 0.01% |
2,485
-5,356
| -68% | -$374K |
|
1314
Goodyear
GT
$1.85B
| $141K | 0.01% |
12,831
-13,967
| -52% | -$155K |
|
1315
Relmada Therapeutics
RLMD
$527M
| $141K | 0.01% |
62,598
-59,992
| -49% | -$207K |
|
|
CLDT
1316
Chatham Lodging
CLDT
$586M
| $139K | 0.01% |
13,241
-3,245
| -20% | -$39.7K |
|
1317
Ribbon Communications
RBBN
$383M
| $139K | 0.01% |
40,657
+5,036
| +14% | +$18.4K |
|
1318
Costamare
CMRE
$1.77B
| $137K | 0.01% |
14,612
-48,184
| -77% | -$475K |
|
1319
ESS Tech
GWH
$18.9M
| $136K | 0.01% |
+6,509
| New | +$181K |
|
1320
MeiraGTx Holdings
MGTX
$1.21B
| $136K | 0.01% |
26,247
-27,557
| -51% | -$191K |
|
1321
Digital Turbine
APPS
$1.74B
| $135K | 0.01% |
10,921
-3,073
| -22% | -$41.3K |
|
1322
Liquidia Corp
LQDA
$8.02B
| $135K | 0.01% |
+19,582
| New | +$134K |
|
1323
MBIA
MBI
$260M
| $134K | 0.01% |
14,478
-33,274
| -70% | -$397K |
|
|
TPIC
1324
DELISTED
TPI Composites
TPIC
| $134K | 0.01% |
10,243
-19,062
| -65% | -$243K |
|
1325
InfuSystem Holdings
INFU
$249M
| $133K | 0.01% |
17,168
-13,756
| -44% | -$127K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, GSA Capital Partners held 2,085 positions worth $1.01B, up 25% from $806M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
GSA Capital Partners deployed $234M of net new capital in Q1 2023, opening 689 new positions and adding to 399 existing holdings. Its largest new stake was National Vision: 167,499 shares worth $3.16M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Transocean, an estimated $2.59M trimmed.
- GSA Capital Partners's largest Q1 2023 buy was National Vision: 167,499 shares worth $3.16M.
- GSA Capital Partners added most to Altimmune in Q1 2023, an estimated $4.45M increase.
- GSA Capital Partners's biggest Q1 2023 reduction was Transocean, cutting an estimated $2.59M.
- GSA Capital Partners fully exited PG&E in Q1 2023, selling an estimated $7.74M.
- GSA Capital Partners's ten largest holdings make up 4.2% of its $1.01B portfolio in Q1 2023.
- GSA Capital Partners opened 689 new positions and closed 654 in Q1 2023.
- GSA Capital Partners's portfolio value rose 25% quarter-over-quarter to $1.01B.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.